{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-001196","form_type":"8-K","ticker":"NUS","cik":"0001021561","company_name":"NU SKIN ENTERPRISES, INC.","filed_at":"2024-01-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.130545+00:00","generated_at":"2026-06-07T01:49:19.943761+00:00","sec_items":["2.02","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Nu Skin Q4 preliminary revenue slightly above guidance; to present at ICR Conference","bullets":["Preliminary Q4 2023 revenue slightly above guidance range; driven by ageLOC WellSpa iO launch, China promotions, and Rhyz performance.","President & CEO Ryan Napierski and CFO James D. Thomas to present at ICR Conference on Jan. 9 at 2:30 p.m. ET.","Full Q4 and full-year 2023 results to be released on Feb. 14 after market close; conference call at 5 p.m. ET.","Webcast replay available through Jan. 23 and Feb. 28 respectively."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-001196","json":"https://secwatch.observer/filing/0001140361-24-001196.json","markdown":"https://secwatch.observer/filing/0001140361-24-001196.md","text":"https://secwatch.observer/filing/0001140361-24-001196.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1021561/000114036124001196/0001140361-24-001196-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1021561/000114036124001196/ef20018262_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T01:49:19.943761+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}